View in EDS

Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses.

Saved in:
Bibliographic Details
Title: Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses.
Authors: Cherney DZI; Division of Nephrology, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada., Rossing P; Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Canziani ME; Universidade Federal de São Paulo, São Paulo, Brazil., Caramori ML; Cleveland Clinic Foundation, Cleveland, Ohio, USA.; University of Minnesota, Minneapolis, Minnesota, USA., Correa-Rotter R; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Cronin L; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA., Hugo C; Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik III, Dresden, Germany., Ji B; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA., Meyerhoff J; Boehringer Ingelheim International, Ingelheim am Rhein, Germany., Nangaku M; University of Tokyo Hospital, Tokyo, Japan., Silva A; Boise Kidney and Hypertension, Nampa, Idaho, USA., Urbach D; Clinical Trials Network, Cape Town, South Africa., Shah SV; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA., de Zeeuw D; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, Groningen, the Netherlands., Tuttle KR; Providence Inland Northwest Health, Spokane, Washington, USA.; University of Washington, Seattle, Washington, USA.
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Jul; Vol. 28 (7), pp. 6324-6333. Date of Electronic Publication: 2026 May 05.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42086479
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cherney+DZI%22">Cherney DZI</searchLink>; Division of Nephrology, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Rossing+P%22">Rossing P</searchLink>; Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Canziani+ME%22">Canziani ME</searchLink>; Universidade Federal de São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Caramori+ML%22">Caramori ML</searchLink>; Cleveland Clinic Foundation, Cleveland, Ohio, USA.; University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Correa-Rotter+R%22">Correa-Rotter R</searchLink>; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Cronin+L%22">Cronin L</searchLink>; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Hugo+C%22">Hugo C</searchLink>; Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik III, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Ji+B%22">Ji B</searchLink>; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Meyerhoff+J%22">Meyerhoff J</searchLink>; Boehringer Ingelheim International, Ingelheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Nangaku+M%22">Nangaku M</searchLink>; University of Tokyo Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Silva+A%22">Silva A</searchLink>; Boise Kidney and Hypertension, Nampa, Idaho, USA.<br /><searchLink fieldCode="AU" term="%22Urbach+D%22">Urbach D</searchLink>; Clinical Trials Network, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Shah+SV%22">Shah SV</searchLink>; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22de+Zeeuw+D%22">de Zeeuw D</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Tuttle+KR%22">Tuttle KR</searchLink>; Providence Inland Northwest Health, Spokane, Washington, USA.; University of Washington, Seattle, Washington, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2026 Jul; Vol. 28 (7), pp. 6324-6333. <i>Date of Electronic Publication: </i>2026 May 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42086479
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/dom.70836
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6324
    Titles:
      – TitleFull: Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cherney DZI
      – PersonEntity:
          Name:
            NameFull: Rossing P
      – PersonEntity:
          Name:
            NameFull: Canziani ME
      – PersonEntity:
          Name:
            NameFull: Caramori ML
      – PersonEntity:
          Name:
            NameFull: Correa-Rotter R
      – PersonEntity:
          Name:
            NameFull: Cronin L
      – PersonEntity:
          Name:
            NameFull: Hugo C
      – PersonEntity:
          Name:
            NameFull: Ji B
      – PersonEntity:
          Name:
            NameFull: Meyerhoff J
      – PersonEntity:
          Name:
            NameFull: Nangaku M
      – PersonEntity:
          Name:
            NameFull: Silva A
      – PersonEntity:
          Name:
            NameFull: Urbach D
      – PersonEntity:
          Name:
            NameFull: Shah SV
      – PersonEntity:
          Name:
            NameFull: de Zeeuw D
      – PersonEntity:
          Name:
            NameFull: Tuttle KR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1463-1326
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Diabetes, obesity & metabolism
              Type: main
ResultId 1